4747 Stock Overview
Johnson Chemical Pharmaceutical Works Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Johnson Chemical Pharmaceutical Works Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$70.30 |
| 52 Week High | NT$88.30 |
| 52 Week Low | NT$58.00 |
| Beta | -0.17 |
| 1 Month Change | 2.78% |
| 3 Month Change | -0.14% |
| 1 Year Change | -2.36% |
| 3 Year Change | 111.43% |
| 5 Year Change | 64.25% |
| Change since IPO | 220.14% |
Recent News & Updates
Recent updates
Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?
Mar 25
These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well
Feb 18Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock
Feb 01Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)
Jan 12
Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?
Dec 25Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?
Dec 07Shareholder Returns
| 4747 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 1.0% | 3.2% | 4.4% |
| 1Y | -2.4% | -12.0% | 1.6% |
Return vs Industry: 4747 exceeded the TW Pharmaceuticals industry which returned -12% over the past year.
Return vs Market: 4747 underperformed the TW Market which returned 1.6% over the past year.
Price Volatility
| 4747 volatility | |
|---|---|
| 4747 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 6.8% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in TW Market | 10.2% |
| 10% least volatile stocks in TW Market | 4.9% |
Stable Share Price: 4747 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4747's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 171 | Baixiong Huang | www.jcpjohnson.com.tw |
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms.
Johnson Chemical Pharmaceutical Works Co., Ltd. Fundamentals Summary
| 4747 fundamental statistics | |
|---|---|
| Market cap | NT$3.16b |
| Earnings (TTM) | NT$85.35m |
| Revenue (TTM) | NT$595.03m |
37.0x
P/E Ratio5.3x
P/S RatioIs 4747 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4747 income statement (TTM) | |
|---|---|
| Revenue | NT$595.03m |
| Cost of Revenue | NT$351.55m |
| Gross Profit | NT$243.48m |
| Other Expenses | NT$158.13m |
| Earnings | NT$85.35m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.90 |
| Gross Margin | 40.92% |
| Net Profit Margin | 14.34% |
| Debt/Equity Ratio | 8.7% |
How did 4747 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield93%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/17 03:46 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Johnson Chemical Pharmaceutical Works Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Regina Lee | Capital Securities Corporation |